Nivolumab With Ipilimumab Combined With TGFβ-15 Peptide Vaccine and Radiotherapy for Pancreatic Cancer
Clinical trial NCT05721846 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05721846
- Sponsor
- Inna Chen, MD
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-03
- Primary completion
- 2026-05-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.